← Open Payments lookup

PAUL NGUYEN: Open Payments

NPI 1740497346 · N LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,801 in 151 payments from 8 companies in 2025. Trend: 2023 $3,004 · 2024 $2,028 · 2025 $2,801

Food & beverage: $2,801
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.53$873
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$488
ABBVIE INC.22$385
Alkermes, Inc.14$315
Vanda Pharmaceuticals Inc.9$225
Supernus Pharmaceuticals, Inc.21$211
Teva Pharmaceuticals USA, Inc.8$166
Neurocrine BioSciences, Inc.5$138

Products named: REXULTI, CAPLYTA, VRAYLAR, ARISTADA, FANAPT, Qelbree, ABILIFY ASIMTUFII, UZEDY.

Industry payments across NV — which companies pay providers there.